Open AccessTargeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors
Author(s) -
Milad Shirvaliloo
Publication year - 2021
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2020-0201
Subject(s) - medicine , sildenafil , tadalafil , covid-19 , vardenafil , hydroxychloroquine , repurposing , severe acute respiratory syndrome , intensive care medicine , disease , infectious disease (medical specialty) , ecology , biology